Garmin
GARMIN LTD
Key figures
Period 2024-12-29 to 2025-12-27ConsolidatedU.S. GAAP
RevenueDisclosed
US$7.2B
Operating marginCalculated
25.9%
Net assets to total assetsCalculated
81.6%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★★★★position among all companies
25.9%
Growth (revenue, 4-year average)
★★★★☆position among all companies
9.8%
Capital efficiency
★★★★☆position among all companies
18.5%
Revenue and profit
Performance, financial position and capital allocation
Garmin
Recent performance trends
Garmin
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$5.0 billion | US$4.9 billion | US$5.2 billion | US$6.3 billion | US$7.2 billion |
| Operating income | US$1.2 billion | US$1.0 billion | US$1.1 billion | US$1.6 billion | US$1.9 billion |
| Net income | US$1.1 billion | US$1.0 billion | US$1.3 billion | US$1.4 billion | US$1.7 billion |
| Total assets | US$7.9 billion | US$7.7 billion | US$8.6 billion | US$9.6 billion | US$11.0 billion |
| Shareholders' equity | US$6.1 billion | US$6.2 billion | US$7.0 billion | US$7.8 billion | US$9.0 billion |
| Net cash provided by (used in) operating activities | US$1.0 billion | US$0.8 billion | US$1.4 billion | US$1.4 billion | US$1.6 billion |
| Net cash provided by (used in) investing activities | US$-0.5 billion | US$-0.1 billion | US$-0.3 billion | US$-0.4 billion | US$-0.6 billion |
| Net cash provided by (used in) financing activities | US$-0.5 billion | US$-0.8 billion | US$-0.6 billion | US$-0.6 billion | US$-0.8 billion |
| Cash and cash equivalents | US$1.5 billion | US$1.3 billion | US$1.7 billion | US$2.1 billion | US$2.3 billion |
Revenue scale in the same industry
Garmin
Instruments and medical devices: 43 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 Thermo Fisher ScientificFY Dec 2025 US$44.6B
- 2 Northrop Grumman Corp /DE/FY Dec 2025 US$42.0B
- 3 MedtronicFY Apr 2026 US$36.4B
- … 14 companies
- 18 Roper TechnologiesFY Dec 2025 US$7.9B
- 19 AmetekFY Dec 2025 US$7.4B
- 20 GarminThis companyFY Dec 2025 US$7.2B
- 21 CoherentFY Jun 2026 US$7.1B
- 22 Agilent TechnologiesFY Oct 2025 US$6.9B
- … 21 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.3 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$2.3 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-0.8 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-0.6 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$1.6 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.2 billion | Consolidated | Disclosed |
| Dividends paid | US$0.7 billion | Consolidated | Disclosed |
| Net assets | US$9.0 billion | Consolidated | Disclosed |
| Net sales | US$7.2 billion | Consolidated | Disclosed |
| Operating income | US$1.9 billion | Consolidated | Disclosed |
| Net income | US$1.7 billion | Consolidated | Disclosed |
| Total assets | US$11.0 billion | Consolidated | Disclosed |
| Operating margin | 25.9% | Consolidated | Calculated |
| Net assets to total assets | 81.6% | Consolidated | Calculated |
| Net margin | 23.0% | Consolidated | Calculated |
| Return on equity | 18.5% | Consolidated | Calculated |